
Chicago-based accelerator for technology companies serving the real estate industry

UK investment manager running tax-efficient EIS funds and a VCT in growth businesses

Specialising in tax-efficient investing, Calculus Capital is a UK fund manager. The firm says it launched the first approved EIS fund in the UK in 1999, and it runs EIS and venture capital trust funds that invest in entrepreneurial UK growth businesses. The funds suit investors who want to back young companies while claiming the tax reliefs the schemes provide.
The firm says it backs the faster growing parts of the UK economy: technology, healthcare and the creative industries. Its portfolio includes Wonderhood, a creative business that combines marketing strategy, technology and entertainment; Booked it, which provides booking, marketing, customer relationship and loyalty software; Ensilitech, whose patent-protected platform encases biological molecules such as vaccines in a silica shell to keep them stable; and Laverock, a gene regulation platform for programmable gene therapies. Other holdings named in its news are Rotageek, which uses cloud-based scheduling so multi-site businesses can manage their staff, Invizius, which is developing treatments that suppress unwanted immune responses, and eConsult Health, which provides online consultations for primary care in the NHS.
Calculus also runs an Inheritance Tax solution, known as ITS, which invests in businesses that extend secured lending to film and television productions.
The firm says these products suit investors with a medium to long term horizon, because exits can take longer than five years and partial withdrawals are generally not possible. Withdrawing early can lead to repayment of tax reliefs: within two years for the inheritance tax solution, three years for the EIS fund and five years for the VCT.
The company describes its EIS funds as award winning. Its recent publications cover the private company business relief market, which it says has drawn fresh attention, and the basics of venture capital trusts in light of the 2026 tax relief changes. It argues that manager quality and investment fundamentals matter more than ever for those choosing a VCT.
Calculus Capital is a investment manager in the UK that specialises in tax-efficient investing. It launched an approved EIS fund in 1999, which it describes as the first in the UK.
It invests in UK growth companies in technology, healthcare and creative industries. Portfolio examples include Rotageek, a staff scheduling platform, Invizius, a biotechnology company, eConsult Health, an online consultation provider to the NHS, and Arctic Shores, a psychometric assessment provider.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Calculus Capital.
Similar listings buyers compare against this one.

Chicago-based accelerator for technology companies serving the real estate industry

Desktop office software with a word processor, spreadsheet, presentations and PDF tools for individuals

Medical device manufacturer making implants and therapies for heart, cancer and spinal conditions

Global startup accelerator and early-stage investor running city and sector programmes for founders

Global software investor backing growth-stage technology companies with capital and in-house operating specialists

San Francisco early-stage technology venture firm led by two founding partners with a stated humane-technology outlook

Icelandic venture firm making early investments in technology founders

Growth-stage venture fund giving expansion capital to entrepreneurs and companies on the cusp of scaling
Everything here links back to the same verified catalogue. Pick your next stop.